((Excerpt))
A Wright State University researcher has been named to a prestigious committee that since the 1970s has reviewed potentially risky research projects, which now focus on curing diseases through human gene transfer.
Dawn Wooley this week will attend her first meeting of the Recombinant DNA Advisory Committee, which reports to the director of the National Institutes of Health, Dr. Francis S. Collins.
Recombinant DNA brings together genetic materials from multiple sources — so it would not otherwise exist. It is found in insect-resistant crops, the hepatitis B vaccine and in some cutting-edge treatments of cancer, said Wooley, who has taught and conducted research on viruses at Wright State since 1995. She works in the Department of Neuroscience, Cell Biology, and Physiology at Wright State’s Boonshoft School of Medicine.
Read more at DaytonDailyNews.com

Wright State receives $3 million grant to strengthen civic literacy and engagement across Southwest Ohio
Fitness Center renovation brings new equipment and excitement to Wright State’s Campus Recreation
Wright State University settles civil lawsuit against WSARC, now doing business as Parallax Advanced Research Corporation
Wright State senior paints a new path through fine arts internship
Wright State recognizes Nursing Professor Kim Ringo for advancing international student success